A comparative study of magnetic-activated cell sorting, cytotoxicity and preplating for the purification of human myoblasts

Yonsei Medical Journal

Volumn 47, Issue 2, 2006, Pages 179-183

  Park, Yoon Ghil ^a   Moon, Jae Ho ^a   Kim, Jin ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Complement mediated cytotoxicity; Magnetic activated cell sorting; Muscular dystrophy; Myoblast; Preplating

Indexed keywords

COMPLEMENT; DESMIN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CELL TRANSPLANTATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; ENRICHMENT CULTURE; FIBROBLAST; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAGNETISM; MIXED CELL CULTURE; MUSCLE TISSUE; MUSCULAR DYSTROPHY; MYOBLAST; PURIFICATION; TREATMENT OUTCOME;

CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; FIBROBLASTS; GENETIC COMPLEMENTATION TEST; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MAGNETICS; MODELS, STATISTICAL; MUSCLE, SKELETAL; MYOBLASTS; TIME FACTORS;

EID: 33646167217     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.2.179     Document Type: Article

References (24)

1. Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988; 333:861-3.
2. Hoffman EP, Brown J, Kunkel LM. Dystrophin: the protein product of the Ducherme muscular dystrophy Iocus. Cell 1987;51:919-28.
3. Huard J, Labrecque C, Dansereau G, Robitaille L, Tremblay JP, Labrecque C, et al. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve 1991;14:178-82.
4. Monaco AP, Neve RL, Colletti-Feener C, Bertlson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portion of the Duchenne muscular dystrophy gene. Nature 1986;323:646-50.
5. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature 1989;337:176-9.
6. Thomas MA, Fast A, Bach JR. Rehabilitation of the patient with disease of the motor unit. In: DeLisa JA, Gans BM, eds. Rehabilitation medicine: principles and practice. Philadelphia: Lippincott Company; 1993. p. 1564-8.
7. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988;333:466-9.
8. Morgan JE, Hoffman EP, Partridge TA. Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J Cell Biol 1990;111:2437-49.
9. Watt DJ, Lambert K, Morgan JE, Partridge TA, Sloper JC. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J Neurol Sci 1982;57:319-31.
10. Watt DJ, Morgan JE, Partridge TA. Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 1984;7:741-50.
11. Chiu R, C, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
12. Kao WW, Prockop DJ. Proline analogue removes fibroblasts from cultured mixed cell population. Nature 1977;266:63-4.
13. Yablonka-Reuveni Z, Nameroff M. Skeletal muscle cell populations. Separation and partial characterization of fibroblast-like cells from embryonic tissue using density centrifugation. Histochemistry 1987;87:27-38.
14. Baroffio A, Aubry JP, Kaelin A, Krause RM, Hamann M, Bader CR. Purification of human muscle satellite cells by flow cytometry. Muscle Nerve 1993;16:498-505.
15. Blanton JR, Jr., Grant AL, McFarland DC, Robinson JP, Bidwell CA. Isolation of two populations of myoblasts from porcine skeletal muscle. Muscle Nerve 1999;22: 43-50.
16. Webster C, Pavlath GK, Parks DR, Walsh FS, Blau HM. Isolation of human myoblasts with the fluorescence-activated cell sorter. Exp Cell Res. 1988;174: 252-6.
17. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-67.
18. Rando TA, Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994;125:1275-87.
19. Qu Z, Huard J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Therapy 2000;58:428-37.
20. Lequerica JL, Mirabet V, Montero JA, Hurtado C, Piquer S, Carbonell F. In vitro proliferation, differentiation and immuno-magnetic bead purification of human myoblasts. Ann Transplant 1999;4:103-96.
21. Jankowski RJ, Haluszczak C, Trucco M, Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 2001;12:619-28.
22. Abboud CN, Duerst RE, Famtz CN, Ryan DH, Liesveld JL, Brennan JK. Lysis of human fibroblast colony-forming cells and endothelial cell by monoclonal antibody (6-9) and complement. Blood 1986;68: 1196-200.
23. Singer KH, Scearce RM, Tuck DT, Whichard LP, Denning SM, Haynes BE. Removal of fibroblasts from human epithelial cell cultures with use of a complement fixing monoclonal antibody reactive with human fibroblasts and monocytes/macrophages. J Invest Dermatol 1989;92:166-70.
24. Simonart T, Degraef C, Heenen M, Hermans P, Van Vooren JP, Noel JC. Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells. J Cutan Pathol 2002;29:72-8.